Naoko Yagishita Selected Research

Biomarkers (Surrogate Marker)

1/2021	An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory biomarkers.
1/2020	Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy/tropical spastic paraparesis treated with steroids.
1/2019	Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
1/2013	CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naoko Yagishita Research Topics

Disease

7	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 12/2022 - 01/2013
4	Inflammation (Inflammations) 01/2021 - 09/2013
4	Spinal Cord Diseases 01/2021 - 01/2015
4	Infections 01/2021 - 01/2011
4	Rheumatoid Arthritis 12/2018 - 02/2008
3	T-Cell Leukemia (Leukemia, T Cell) 01/2021 - 01/2019
3	Disease Progression 01/2021 - 01/2013
3	Fibrosis (Cirrhosis) 12/2018 - 01/2015
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2018 - 10/2010
3	Joint Diseases (Joint Disease) 02/2008 - 10/2003
2	Body Weight (Weight, Body) 01/2018 - 04/2015
1	Overactive Urinary Bladder (Overactive Bladder) 01/2021
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2020
1	Herpes Zoster 10/2019
1	Neoplasms (Cancer) 10/2019
1	Persistent Infection 10/2019
1	Obesity 12/2018
1	Metabolic Diseases (Metabolic Disease) 12/2018
1	Hyperplasia 12/2017
1	Weight Gain 04/2015
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2015
1	Adenocarcinoma of Lung 01/2015
1	Liver Diseases (Liver Disease) 04/2014
1	Experimental Arthritis 12/2011
1	Necrosis 01/2011
1	Osteoarthritis 01/2011

Drug/Important Bio-Agent (IBA)

8	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2018 - 10/2003
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 12/2017 - 03/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022 - 01/2021
2	NeopterinIBA 01/2020 - 01/2013
2	SteroidsIBA 01/2020 - 10/2019
2	ChemokinesIBA 01/2019 - 09/2013
2	mogamulizumabIBA 01/2018 - 01/2015
2	LS-102IBA 04/2015 - 01/2015
2	CollagenIBA 01/2015 - 10/2010
2	Small Interfering RNA (siRNA)IBA 12/2011 - 01/2011
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2021
1	mirabegronIBA 01/2021
1	Cell Adhesion Molecule-1IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	Viral DNAIBA 10/2019
1	Pharmaceutical PreparationsIBA 12/2018
1	CytokinesIBA 12/2017
1	Prednisolone (Predate)FDA LinkGeneric 10/2017
1	Protein CIBA 01/2015
1	Surface-Active Agents (Surfactants)IBA 01/2015
1	Extracellular Matrix ProteinsIBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 08/2014
1	Viral ProteinsIBA 08/2014
1	AntioxidantsIBA 04/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2014
1	Chemokine CXCL10IBA 01/2013
1	AntibodiesIBA 12/2011
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 12/2011
1	Polysaccharides (Glycans)IBA 01/2011
1	ProstaglandinsIBA 01/2011
1	fucoidanIBA 01/2011
1	Collagenases (Collagenase)FDA Link 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 01/2011
1	Interleukin-6 (Interleukin 6)IBA 01/2011
1	butaprostIBA 01/2011
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2011
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2011
1	LuciferasesIBA 01/2011
1	EnzymesIBA 10/2003

Therapy/Procedure

2	Therapeutics 12/2022 - 01/2019